BIOA
BioAge Labs, Inc.
Pharmaceutical PreparationsNasdaq<br>Emerging growth company
Total Trades
18
Buys
5
Sells
7
Largest Trade
$1M+
Insiders
7
Institutional Funds
80
Inst. Value
$1M+
Activist Filings
11
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| RUBIN PAUL D | Chief Medical Offi… | SELL | $100K–$500K | 7K | $20.30 | Mar 3, 2026 |
| RUBIN PAUL D | Chief Medical Offi… | EXERCISE | $15K–$50K | 7K | $4.77 | Mar 3, 2026 |
| RUBIN PAUL D | Chief Medical Offi… | EXERCISE | $15K–$50K | 7K | $4.77 | Feb 3, 2026 |
| RUBIN PAUL D | Chief Medical Offi… | SELL | $100K–$500K | 7K | $18.75 | Feb 3, 2026 |
| GOLDSTEIN DOV A MD | CFO | EXERCISE | $100K–$500K | 27K | $8.39 | Jan 15, 2026 |
| GOLDSTEIN DOV A MD | CFO | SELL | $500K+ | 27K | $19.70 | Jan 15, 2026 |
| Fortney Kristen | CEO | SELL | $1M+ | 233K | $18.12 | Jan 15, 2026 |
| RUBIN PAUL D | Chief Medical Offi… | SELL | $50K–$100K | 7K | $12.85 | Jan 6, 2026 |
| RUBIN PAUL D | Chief Medical Offi… | EXERCISE | $15K–$50K | 7K | $4.77 | Jan 6, 2026 |
| RUBIN PAUL D | Chief Medical Offi… | EXERCISE | $100K–$500K | 18K | $6.57 | Dec 11, 2025 |
| RUBIN PAUL D | Chief Medical Offi… | SELL | $100K–$500K | 18K | $12.00 | Dec 11, 2025 |
| RUBIN PAUL D | Chief Medical Offi… | SELL | $500K+ | 69K | $10.19 | Dec 5, 2025 |
| RUBIN PAUL D | Chief Medical Offi… | EXERCISE | $100K–$500K | 69K | $4.11 | Dec 5, 2025 |
| Pande Vijay Satyanand | Director | BUY | $1M+ | 219K | $19.75 | Oct 3, 2024 |
| Cormorant Asset Management, LP | Insider | BUY | $1M+ | 450K | $18.00 | Oct 1, 2024 |
| Pande Vijay Satyanand | Director | BUY | $1M+ | 900K | $18.00 | Sep 27, 2024 |
| ENRIGHT PATRICK G | Director | BUY | $1M+ | 400K | $18.00 | Sep 27, 2024 |
| HEALY JAMES | Director | BUY | $1M+ | 667K | $18.00 | Sep 27, 2024 |
🔓Seeing ranges? Sign in for exact trade values — free forever
Institutional Ownership
13F filings as of Dec 31, 2025 · 80 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| a16z Capital Management, L.L.C. | 3.2M | $1M+ | SH |
| Sofinnova Investments, Inc. | 2.3M | $1M+ | SH |
| Cormorant Asset Management, LP | 2.0M | $1M+ | SH |
| Octagon Capital Advisors LP | 1.6M | $1M+ | SH |
| VANGUARD GROUP INC | 1.2M | $1M+ | SH |
| ORBIMED ADVISORS LLC | 791K | $1M+ | SH |
| Sands Capital Alternatives, LLC | 786K | $1M+ | SH |
| Pivotal bioVenture Partners Investment Advisor LLC | 653K | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 507K | $1M+ | SH |
| COSMIC MANAGEMENT, LLC | 502K | $1M+ | SH |
| STATE STREET CORP | 423K | $1M+ | SH |
| Redpoint Management, LLC | 383K | $1M+ | SH |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 334K | $1M+ | SH |
| ACADIAN ASSET MANAGEMENT LLC | 278K | $1M+ | SH |
| SPHERA FUNDS MANAGEMENT LTD. | 243K | $1M+ | SH |
| MARSHALL WACE, LLP | 223K | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 220K | $1M+ | SH |
| MORGAN STANLEY | 149K | $1M+ | SH |
| ADAR1 Capital Management, LLC | 136K | $1M+ | SH |
| ADAR1 Capital Management, LLC | 136K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Feb 17, 2026
0.4%
136K shares
Cormorant Asset Management, LP
SC 13G/A · Feb 17, 2026
5.7%
2.0M shares
SC 13G/A · Feb 13, 2026
7.2%
2.7M shares
SC 13G · Aug 15, 2025
5.4%
1.9M shares
Cormorant Asset Management, LP
SC 13G/A · Aug 14, 2025
6.0%
2.1M shares
SC 13G/A · Feb 14, 2025
3.7%
1.3M shares
Cormorant Asset Management, LP
SC 13G · Feb 14, 2025
7.3%
2.6M shares
SC 13G · Nov 14, 2024
1.2%
437K shares
SC 13G · Nov 12, 2024
6.6%
2.3M shares
SC 13G · Oct 7, 2024
6.2%
2.2M shares
SC 13D · Oct 5, 2024
3.5%
1.3M shares